Market Access at eyeforpharma Barcelona
March 12 - 14, 2019 - Barcelona UKeyeforpharma
jmackintosh@eyeforpharma.com
Phone:+4402073757163
Key Themes Explored in 2019 Build the market access ecosystem: Foster genuine payment innovation with stakeholder collaboration to match rapidly increasing treatment effectiveness Access at Day 1: Make market access a company-wide imperative, from the start of development through commercialisation Translate patient to payer value: Find KPIs which justify pricing models through measuring real patient journeys Big data, bigger opportunity: Ensure real-world evidence meets payer standards to guarantee decision-making impact The event will be driven by pharma senior executives and key stakeholders across the industry, including: Martin Price, VP, HEOR, Market Access and Reimbursement, Janssen Daniel Jackson, Global Head, Market Access Solutions and Strategy, UCB Gillian Leng, Deputy Chief Executive Officer, NICE Giuseppe Rosano, Member CVWP, European Medicines Agency, Consultant Cardiologist, Agenzia Italiana del Farmaco Ruediger Papsch, Senior Director, Global Head Market Access and Pricing Fertility, Merck KGaA